BASF Venture Capital and Xiamen C&D are among the limited partners in Longwater Investment’s advanced materials-focused fund, which was already backed by Solvay.

Gil Ahrens, formerly head of venture capital and emerging growth coverage at Wells Fargo Securities, is set to reprise his role at Deutsche Bank.

GlaxoSmithKline, Novartis and Astellas are among the investors to have celebrated an exit after cancer therapy developer Bicycle secured $60.7m in its initial public offering.

Adevinta formed part of a consortium that supplied $3.5m in series A funding to Kodit.io alongside a $10.5m loan to purchase real estate.

The vehicle is the fifth fund to be established by Salesforce under the Trailblazer banner and follows entities focusing on Canada, Japan and Australia.

Existing backer Virgin Group returned to reinvest in intimate gig promoter Sofar Sounds, which just celebrated its 10th birthday.

The Mitsui and Virgin-backed money transfer service more than doubled its valuation to $3.5bn in a round that involved existing backers selling shares.

Medtronic, LivaNova and Baxter Healthcare have helped commit $53.5m for the third medical device-based fund to be raised under the MD Start moniker.

Jacqueline LeSage Krause of Munich Re Ventures and David Gilmour of BP Ventures are co-chairs of this year’s GCV Symposium, which is looking at how to navigate market turbulence.

Seraphim Capital’s Space Camp Accelerator, which counts a number of corporates among its investors, has picked out its third cohort of space technology innovators.